Key Highlights
- Pharmaceutical company Sanofi introduced “Concierge for Field,” an AI-powered assistant developed using Snowflake Cortex AI technology to streamline sales representative preparation
- The innovative tool delivers comprehensive pre-call planning in mere seconds, transforming what was previously an hours-long manual task
- The company has consolidated its entire data infrastructure on Snowflake’s cloud platform and is deploying AI solutions across multiple departments including R&D, procurement, IT, HR, and commercial sales
- Technology partner Elementum collaborates on the initiative, creating applications that operate natively within Snowflake’s ecosystem
- The reveal took place during Snowflake Summit 26 on June 2, 2026; SNOW shares dropped 8.48% while SASY declined 0.97% during trading
The French pharmaceutical corporation Sanofi has introduced an artificial intelligence-powered assistant aimed at streamlining how its worldwide sales representatives prepare for meetings with healthcare providers. Dubbed “Concierge for Field,” the innovative solution made its debut during Snowflake Summit 26 on June 2, 2026.
Snowflake (SNOW) experienced an 8.48% decline that trading day, while Sanofi’s American Depositary Receipt (SASY) fell 0.97%.
The intelligent assistant operates on Snowflake Cortex AI infrastructure. Sales professionals can request comprehensive pre-call planning through a simple conversational interface and receive detailed results almost instantly.
The generated plan identifies the top-priority healthcare provider based on medical specialty and prescription patterns, summarizes previous interactions, and delivers a fully prepared strategy directly to the representative’s email.
According to Sanofi, this workflow previously consumed multiple hours of tedious manual research. The entire process now completes through a simple conversation.
This capability represents one element of Sanofi’s comprehensive initiative to integrate artificial intelligence throughout its operations. The pharmaceutical company has consolidated its data infrastructure on Snowflake’s cloud platform and is implementing AI agents throughout research and development, supply chain management, information technology, human capital management, and commercial sales operations.
Technology partner Elementum plays a crucial role in this infrastructure. Elementum develops enterprise applications that execute natively within the Snowflake ecosystem, displacing what they characterize as outdated SaaS solutions.
Shifting from Static Reports to Intelligent Automation
Emmanuel Frenehard, Sanofi’s Chief Digital Officer, explained that the organization invested years constructing data pipelines simply to gain access to its own information. The current architecture addresses that fundamental challenge.
“We are constructing AI capabilities directly on our data foundation and transforming how the entire organization operates, spanning R&D through manufacturing to commercial activities,” Frenehard stated. “This approach positions Sanofi to become the first biopharmaceutical company powered by AI at enterprise scale.”
The identical Snowflake infrastructure powering the sales assistant also enables Sanofi’s scientific research divisions. Research teams leverage it to analyze real-world clinical information at massive scale, which the company indicates speeds up pharmaceutical development timelines.
Snowflake CEO Sridhar Ramaswamy noted the collaboration demonstrates the advantages of constructing AI capabilities on unified enterprise data rather than adding them to fragmented legacy infrastructure.
Snowflake Deploys Dedicated Engineering Resources Within Sanofi
Snowflake’s Forward Deployed Engineers — a specialized unit comprising AI engineers, data scientists, and domain experts — are collaborating directly alongside Sanofi’s technology and engineering personnel to expand these capabilities.
The partnership ensures AI-powered workflows operate on a unified, governed data foundation instead of being distributed across numerous third-party platforms.
Sanofi’s initiative reflects a broader pharmaceutical industry trend toward accelerating both commercial functions and drug discovery using AI-native technology infrastructure.
The “Concierge for Field” assistant represents the most prominent result of this strategy to date, with additional AI implementations scheduled throughout the organization.
